Allinecin Inj.

(Fursultiamine hydrochloride) ETC Drug

Component

Fursultiamine Hydrochloride(KP) in 1 ampoule (10mL)---54.6mg (50mg as fursultiamine)

Identification

An injection liquid of pale or light yellow color contained in a brown transparent glass ampoule

Efficacy / Effect

1. Prevention and treatment of vitamin B1 deficiency
2. Supply when the demand for vitamin B1 increases and the vitamin B1 intake from food is insufficient (wasting diseases, hyperthyroidism, pregnancy, nursing mothers, after intense physical labor, etc.)
3. Wernicke's encephalopathy
4. Beriberi heart disease
5. If it is estimated that vitamin B1 deficiency or metabolic disorder is involved due to the following diseases:
1) Neuralgia
2) Muscle pain, joint pain
3) Peripheral neuritis, peripheral nerve paralysis
4) Myocardial metabolism disorder
5) Gastrointestinal dysfunction such as constipation
6) Intestinal paralysis after surgery

Dosage

As fursultiamine, 5 to 100 mg per day for adults usually subcutaneously, intramuscularly, or intravenously.
Increase or decrease according to symptoms.

Storage / Shelf life

Light-resistant hermetic container, Storage at room temperature (1 - 30℃) / 36 months from the date of manufacture

Packing Unit

10mL * 10A